IMPORTANT INFORMATION FOR INVESTORS OF HONG KONG

Please read this important information before proceeding further. Zurich Invest ICAV (the “Scheme”) is domiciled in Ireland and its home regulator is the Central Bank of Ireland.

Each of the Sub-Fund under the Scheme has a different investment objective and risk profile investing primarily in other collective investment schemes (“CIS”). These other CIS may invest directly in various investments, such as but not limited to, equities and equity related securities, alternative investments, bonds and other debt securities.

  1. The Sub-Fund and/or the underlying CIS’s investment portfolio may fall in value due to any of the key risk factors below. Therefore, your investment in the Sub-Fund may suffer losses. There is no guarantee of the repayment of principal.
  2. The Sub-Fund may invest in other CIS and will be subject to the risks associated with Sub-Fund’s underlying CIS. The Sub-Fund does not have control of the investments of the underlying CIS. There is no assurance that the investment objective and strategy of the underlying CIS will be successfully achieved which may have a negative impact to the net asset value of the Sub-Fund. The underlying CIS may not be regulated by the Securities and Futures Commission (“SFC”). Additional costs may be involved when investing into these underlying CIS. The underlying CIS may not always have sufficient liquidity to meet the Sub-Fund’s redemption requests.
  3. The Sub-Fund’s investments and/or through investments in underlying CIS are subject to currency risk.
  4. The Sub-Fund’s investments and/or through investments in underlying CIS investing equity securities are subject to general market and volatility risks.
  5. The Sub-Fund’s investments and/or through investments in underlying CIS investing in bonds and other debt securities that are subject to related risks such as credit/counterparty risk, interest rates risk, downgrading risk, risk associated with debt securities rated below investment grade or unrated, sovereign debt risk.
  6. The Sub-Fund’s investments and/or through investments in underlying CIS investing in financial derivative instruments (“FDI”) that are subject to counterparty/credit risk, liquidity risk, valuation risk, volatility risk and over-the-counter transaction risk. Exposure to FDI may lead to a high risk of significant loss by the Sub-Fund.
  7. Investors may suffer substantial loss of their investments in the Sub-Fund. Investor should not invest in the Sub-Fund solely based on the information provided in this website and should read the offering documents, including Product Key Facts (including the risk factors) for details.

Investment involves risk and may lose value. If you are considering making an investment, you are advised to obtain your own independent professional advice and to carefully consider all relevant risk factors. The value of investments and any income from them may go down as well as up. Investors should read the offering documents of the Schemes for further details including related risk factors. Past performance is not indicative of future performance. The information contained in this website is not intended as an offer to sell securities or a solicitation to buy the Schemes. The goal is to provide general information on the Schemes that have been authorized for retail sale in Hong Kong. The Schemes referred to in this website are authorized by the Securities and Futures Commission (“SFC”).

Please note that SFC authorization is not an official recommendation or endorsement of a Scheme nor does it guarantee the commercial merits of a Scheme or its performance. It does not mean the Scheme is suitable for investors nor is it an endorsement of its suitability for any particular investor or class of investors. The material contained in this website has not been reviewed by the SFC.


Links to Other Websites

Although there may be certain links between this website and one or more websites operated by third parties or other parties and third party content and other content may be displayed in the website, or available through a hyperlink from our website leading to another webpage or website or browser, we have no control over any such other websites, the contents therein or the products/services offered. The existence of any such links shall not constitute an endorsement of, or representation or warranty by us regarding such websites, the contents of the websites, the products or services of the websites or the operators of the websites. Your access to and use of such linked websites is governed by the terms of use and privacy policies of those sites, and shall be at your own risk. In addition, please note that such contents or information may not be intended for persons located or residing in jurisdictions that restrict the distribution of such content and you should consult and carefully read the applicable terms and conditions before using the website(s).


Note: You cannot proceed further without accepting the terms.

Zurich Invest ICAV

Here you will be able to download the relevant Hong Kong documents of the schemes of Zurich Invest ICAV which are authorized in Hong Kong (“Scheme(s)”). Hong Kong investors should carefully read the Scheme(s) latest Hong Kong offering documents, hard copies are available from the office of the Schemes Hong Kong Representative, State Street Trust (HK) Limited, 68/F, Two International Finance Centre, 8 Finance Street, Central, Hong Kong, for further details, including related risk factors, before deciding to invest in any Scheme(s).

Investment involves risk and may lose value. Past performance is not indicative of future performance. The Schemes referred to in this website are authorized by the Securities and Futures Commission (“SFC”) in Hong Kong. You should exercise care accordingly.

Authorization of the Scheme(s) by SFC in Hong Kong is not a recommendation or endorsement of such Scheme(s) nor does it guarantee the commercial merits of such Scheme(s) or its performance. It does not mean the Scheme(s) is/are suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors.

 

Supplementary Documents to the Prospectus

The documents listed below are the Supplement dated 25 May 2022 to the Prospectus on 10 September 2021. These supplements contain specific information in relation to the sub-funds of Zurich Invest ICAV :

Product Key Facts Statements, Audited Reports, Other Reports

Schemes – Zurich Invest ICAV Product Key Facts Statements
 Zurich Blue Adventurous Fund  Click to view
 Zurich Blue Performance Fund  Click to view
 Zurich Blue Balanced Fund  Click to view
 Zurich Blue Cautious Fund  Click to view

Note: Investors should note that the aforementioned audited annual reports and/or unaudited interim reports may contain information on schemes which are not authorized for sale to the Hong Kong retail public. Schemes which are not available for sale to the Hong Kong retail public will be clearly marked as such in the relevant report(s), where appropriate.

 

Enquiries / Contact

If investors in Hong Kong have any enquiries or complaints, please contact the Scheme’s Hong Kong Representative, State Street Trust (HK) Limited, 68/F, Two International Finance Centre, 8 Finance Street, Central, Hong Kong. Or by telephone at +852 3667 7111 or by facsimile at +852 2805 0101.